30 November 2022,Raffles PharmaTech has successfully obtained a Drug Manufacturing License issued by the Guangdong NMPA, certificate No.粤20220025,classification code Dh.
The recognition by the regulatory authority marks an important development milestone for the company.
About Us
1
Raffles PharmaTech was created in 2011 by scientists from leading global companies driven to build a platform for world-class small molecule development and cGMP manufacturing.
2
The company with head-quarters in Guangdong, China, currently employs more than 450 staff supporting Innovative pharmaceutical development across the globe.
3
With Chemistry at the core of the organization the company engages in route discovery,process development, optimization,scale-up and cGMP manufacture of Key materials, Intermediates, Active Pharmaceutical Ingredients.
4
Route discovery, process development, optimization, scale-up and cGMP manufacture.KRMs,RSMs, Intermediates, APIs.
Support Platforms Overview
Early Study Lab Scale Synthesis
Early Phase Process Development
Clinical Trial APIs & Late Phase RSMs
IND,NDA to Commercial Supply Analytical Open Lab
Chemical Analytical Service Lab Analytical Research Development to QC cGMP QC/QA System